The Real Economy Blog

Health Care

From hospital systems to home care providers, the health care sector is replete with middle market companies. The health needs of an aging population assure that this industry will continue to grow in coming years.

5 things to know in life sciences: Week of April 5

by

As the months of 2021 tick by, the percentage of Americans vaccinated is rapidly increasing. This offers the hope of a return to more normal life but also raises new questions, including whether companies can mandate vaccines or how we track the virus. We also look at the lack of diversity on the boards of life sciences companies, Food and Drug ... READ MORE >

5 things to know in life sciences: Week of March 29

by , and

Each week, we highlight five things you need to know about in the life sciences industry. Here’s the latest. 1. FTC challenges biopharma merger as antitrust scrutiny grows Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the biopharmaceutical industry, the proposed Illumina and Grail ... READ MORE >

5 things to know in life sciences: Week of March 22

by , and

In this week’s life sciences roundup: the AstraZeneca-Oxford COVID-19 vaccine has faced challenging headwinds in the past week as several European Union countries paused distribution pending additional information from the European Medicines Agency, and as the National Institute of Allergy and Infectious Diseases in the United States publicly rebuked data ... READ MORE >

5 things to know in life sciences: Week of March 15

by , and

The Federal Trade Commission’s new acting chair, Rebecca Kelly Slaughter, has initiated a review of the agency's processes for approving pharma mergers. This is expected to result in a tougher road for these mergers, as we explain below. We also look at the top drugs losing their exclusivity this year, artificial intelligence-powered hearing aids and the use ... READ MORE >

Understanding the rapid spread of COVID-19 variants

by and

As of March 12, more than 341 million doses of COVID-19 vaccines have been administered globally at a remarkable pace of 8.5 million doses a day, according to Bloomberg. Nearly a third of those vaccinations have occurred in the United States, where we have already administered more than 101 million doses and are giving another 2.3 million doses a day. ... READ MORE >

Pandemic recovery signals new ways health care can serve and grow

by

Health care services are poised to lead the services recovery for the next two years, according to analysis from the UCLA Anderson School of Management. Not only will providers benefit from the return of pre-pandemic volumes, but the increasing likelihood of an endemic virus may present new ways for providers to serve their patients and communities. The ... READ MORE >

Building the new normal in health care

by and

As the health care industry works toward a new normal—a time of recovery and eventual re-emergence from the pandemic—providers are taking a hard look at their physical infrastructure and rethinking what they will need in the future. This rethinking has been prompted in no small part by the explosion of telemedicine during the pandemic and the ... READ MORE >

5 things to know in life sciences: Week of Feb. 22

by , and

In this week’s roundup we look at two important developments in the ongoing response to the pandemic. The first is the likelihood that Johnson & Johnson’s vaccine could be approved under an emergency use authorization (EUA) as early as this weekend. The second is a major new effort by the U.S. government to expand genomic sequencing to track new COVID-19 ... READ MORE >